[ARWR] QoQ Quarter Result on 30-Sep-2017 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
12-Dec-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q4]
Profit Trend
QoQ- -94.42%
YoY- 51.71%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 727 650 3,510 8,714 9,342 8,986 4,365 -69.82%
PBT -15,606 -14,884 -13,199 -10,729 -5,520 -6,043 -12,086 18.63%
Tax 0 -150 -614 2 -194 -81 -1,509 -
NP -15,606 -14,884 -13,199 -10,732 -5,520 -6,043 -12,086 18.63%
Tax Rate - - - - - - - -
Total Cost 16,333 15,534 16,709 19,446 14,862 15,028 16,452 -0.48%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -2,145.53 -2,289.45 -376.06 -123.16 -59.08 -67.24 -276.86 293.07%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.18 -0.18 -0.18 -0.14 -0.07 -0.08 -0.17 3.89%
EPS Diluted -0.18 -0.18 -0.18 -0.14 -0.07 -0.08 -0.17 3.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.